Chinese Academy of Medical Sciences & Peking Union Medical College

Researchers

• WLWeimin Li
• XSXiaoyan Si
• YSYinghong Shi

Running trials

• Recruiting

  IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer

  NCT07377643· Phase 3· Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.· Source

• Not yet recruiting

  Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma

  NCT07353554· Peking Union Medical College Hospital· Source

• Not yet recruiting

  Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD)

  NCT07173933· Phase 1/2· GeneCradle Inc· Source

• Recruiting

  68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision

  NCT06949215· Phase 2· Peking Union Medical College Hospital· Source

• Recruiting

  Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC)

  NCT06793813· Phase 2· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Source

• Active, not recruiting

  FCN-159 in Adult Patients With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas

  NCT05913037· Phase 3· Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.· Source

• Active, not recruiting

  Evaluation of the Safety and Efficacy of Infantile-onset Pompe Disease Gene Therapy Drug

  NCT05793307· Phase 1/2· GeneCradle Inc· Source

• Active, not recruiting

  Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC

  NCT05888402· Phase 2· Cancer Institute and Hospital, Chinese Academy of Medical Sciences· Source

• Active, not recruiting

  Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia

  NCT05577312· Phase 1/2· Bioray Laboratories· Source

• Recruiting

  Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer

  NCT05751018· Phase 2· Peking Union Medical College Hospital· Source

• Active, not recruiting

  A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer

  NCT05077449· Phase 3· Xuanzhu Biopharmaceutical Co., Ltd.· Source

• Enrolling by invitation

  Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection

  NCT04762459· Phase 3· Chinese Academy of Medical Sciences· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer3 recruiting
• Kidney cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple myeloma1 recruiting
• Wilson disease1 recruiting

Conditions

Diseases this institution publishes on or runs trials for.

• Lung cancer563 works · 4 trials
• Stroke407 works · 0 trials
• Liver and biliary tract cancer356 works · 0 trials
• Heart failure355 works · 0 trials
• Colorectal cancer296 works · 0 trials
• Obesity272 works · 0 trials
• Gastric and oesophageal cancer240 works · 0 trials
• Type 2 diabetes189 works · 0 trials
• Atrial fibrillation164 works · 0 trials
• Alzheimer disease161 works · 0 trials
• Cervical cancer140 works · 0 trials
• Coronary artery disease134 works · 0 trials
• Pancreatic cancer124 works · 0 trials
• Prostate cancer123 works · 0 trials
• Deep vein thrombosis and pulmonary embolism108 works · 0 trials
• COPD108 works · 0 trials
• Lupus (SLE)100 works · 0 trials
• Acute myeloid leukaemia97 works · 0 trials
• Chronic kidney disease95 works · 0 trials
• Triple-negative breast cancer92 works · 0 trials
• Melanoma85 works · 0 trials
• Ovarian cancer84 works · 0 trials
• Asthma78 works · 0 trials
• HIV78 works · 0 trials
• Psoriasis78 works · 0 trials
• Bladder cancer77 works · 0 trials
• Tuberculosis76 works · 0 trials
• Kidney cancer71 works · 1 trial
• Glioblastoma68 works · 0 trials
• Parkinson disease67 works · 0 trials